These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7987622

  • 1. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A, George J, Sachar DB.
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [Abstract] [Full Text] [Related]

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 4. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 5. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Jul 15; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R, Horgan K.
    Semin Gastrointest Dis; 1998 Jan 15; 9(1):2-9. PubMed ID: 9547850
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 15; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 10. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 01; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 12. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T, Korelitz BI.
    Am J Gastroenterol; 1994 Mar 01; 89(3):362-6. PubMed ID: 8122645
    [Abstract] [Full Text] [Related]

  • 13. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF, Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
    Gastroenterology; 2006 Apr 01; 130(4):1054-61. PubMed ID: 16618399
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI.
    Gastroenterologist; 1995 Jun 01; 3(2):141-52. PubMed ID: 7640945
    [Abstract] [Full Text] [Related]

  • 15. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 16. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA, Petritsch W, Aichbichler B, Fickert P, Ranner G, Krejs GJ.
    Z Gastroenterol; 1997 Aug 01; 35(8):603-8. PubMed ID: 9297775
    [Abstract] [Full Text] [Related]

  • 17. [Drug treatment of Crohn's disease].
    van Deventer SJ, Tytgat GN.
    Ned Tijdschr Geneeskd; 1998 May 23; 142(21):1191-5. PubMed ID: 9627451
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec 23; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar 23; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.